Cargando…
Corrigendum to “mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19” [Gene Rep. 20 (2020) 100765]
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883700/ https://www.ncbi.nlm.nih.gov/pubmed/33615040 http://dx.doi.org/10.1016/j.genrep.2021.101054 |
| _version_ | 1783651264078282752 |
|---|---|
| author | Ramaiah, Mekala Janaki |
| author_facet | Ramaiah, Mekala Janaki |
| author_sort | Ramaiah, Mekala Janaki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7883700 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78837002021-02-16 Corrigendum to “mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19” [Gene Rep. 20 (2020) 100765] Ramaiah, Mekala Janaki Gene Rep Corrigendum Elsevier Inc. 2021-09 2021-02-15 /pmc/articles/PMC7883700/ /pubmed/33615040 http://dx.doi.org/10.1016/j.genrep.2021.101054 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Corrigendum Ramaiah, Mekala Janaki Corrigendum to “mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19” [Gene Rep. 20 (2020) 100765] |
| title | Corrigendum to “mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19” [Gene Rep. 20 (2020) 100765] |
| title_full | Corrigendum to “mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19” [Gene Rep. 20 (2020) 100765] |
| title_fullStr | Corrigendum to “mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19” [Gene Rep. 20 (2020) 100765] |
| title_full_unstemmed | Corrigendum to “mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19” [Gene Rep. 20 (2020) 100765] |
| title_short | Corrigendum to “mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19” [Gene Rep. 20 (2020) 100765] |
| title_sort | corrigendum to “mtor inhibition and p53 activation, micrornas: the possible therapy against pandemic covid-19” [gene rep. 20 (2020) 100765] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883700/ https://www.ncbi.nlm.nih.gov/pubmed/33615040 http://dx.doi.org/10.1016/j.genrep.2021.101054 |
| work_keys_str_mv | AT ramaiahmekalajanaki corrigendumtomtorinhibitionandp53activationmicrornasthepossibletherapyagainstpandemiccovid19generep202020100765 |